Background and Aims: Patients with asthma-chronic obstructive pulmonary disease overlap (ACO) have both clinical features of asthma and chronic obstructive pulmonary disease (COPD). Bronchial thermoplasty (BT) is a novel non-pharmacological, endoscopic treatment for patients with severe asthma. However, there is currently no guideline to suggest that BT is one of the treatments for patients with ACO.
the patient developed pneumonia after the third procedure of BT, it recovered very well after anti-inflammatory treatment and left no sequelae.
Conclusion:
It is the first report to describe a patient with ACO who underwent BT treatment. It suggests that BT may be a new treatment for ACO and more studies will be needed to identify this in the future. Singapore. Apart from deaths due to asthma, there is much morbidity due to disease exacerbations and days lost from work and school from asthma.
Aims: This study is to ascertain that a structured disease management program does impact on the over control of the asthma patients.
Methods: Systematic reviews have shown that patient education and optimizing drug treatment can have major sustained beneficial effects in patients. A structure management programme was implemented with nurse educators and data entry clerks being employed to the programme. 50% drug subsidies accord to patients who were prescribed with asthma medication.
Under the Programme: The asthma nurse educator will record all the necessary parameters and provide the necessary educational information and tools. She monitors the treatment and compliance with the help of Action Plans. All clinic attendances are monitored and in the case of failure of attendance, the nurse will contact the patient over phone and arrange a new appointment, or refer to the social worker if social intervention is required. Results: 32% doctors encountered minimum 5 patients with asthma daily. 70% doctors said most of their patients were >25 years old. Only 6.3% doctors used spirometry regularly for diagnosing asthma, 28% did not use lung function measuring tools. For patients with uncontrolled asthma, doctors did follow-up every month. Fluticasone was the most preferred ICS (65%-doctors); Salmeterol/fluticasone was the most preferred LABA/ICS (77%-doctors). Only, 40% doctors prescribed inhalation therapy to all their patients. Almost 62% doctors believed that >40% of their patients were apprehensive to use inhalers for which lack of awareness and cost of treatment were believed to be the most common reasons. 84% doctors preferred prescribing pMDI with or without spacer. 70% doctors preferred prescribing similar devices for reliever and controller medications both as they believed that using similar device would be easier for patients. Only 11% doctors perceived that >70% patients showed >80%
adherence to inhalation therapy. Almost 60% doctors evaluated patients' inhalation technique when they suspected it to be wrong while others checked it at every visit. Major factors for poor asthma control were incorrect inhaler technique and non-adherence. High cost of medication and skipped medicines in absence of symptoms were major factors of nonadherence Conclusion: Use of spirometry can be increased for diagnosing and confirming asthma. pMDI-with or without spacer was the most preferred choice for managing asthma. Regular and repeated device technique demonstration can improve adherence and asthma control. , HIROYUKI NAGASE
